ID

39016

Description

Along-term Study of OPC-262 in Patients With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01634282

Lien

https://clinicaltrials.gov/show/NCT01634282

Mots-clés

Versions (1)
  1. 20/11/2019 20/11/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

20 novembre 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes, Type 2 NCT01634282

Anglais

Eligibility Diabetes, Type 2 NCT01634282

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients who completed study 262-09-001 (namely, patients who visited the hospital at visit week 24）
Description

Clinical Trial Specified Completed

Type de données

boolean

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0205369
UMLS CUI [1,3]
C0205197
patients who are capable of giving informed consent prior to participating in this clinical study
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
patients who are able to take contraceptive measures to avoid pregnancy of the patient or the patient's partner for the entire study period and for 4 weeks after the study (end of the post-observation period)
Description

Contraceptive methods | Partner Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1]
C0700589
UMLS CUI [2,1]
C0682323
UMLS CUI [2,2]
C0700589
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who withdrew from study 262-09-001
Description

Patients Withdrawn Clinical Trial Specified

Type de données

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C2349954
UMLS CUI [1,3]
C0008976
UMLS CUI [1,4]
C0205369
patients who experienced serious adverse events that the relationship with the study drug was not denied in study 262-09-001
Description

Serious Adverse Event | Relationship Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1]
C1519255
UMLS CUI [2,1]
C0439849
UMLS CUI [2,2]
C0013230
patients who experienced serious adverse events that the relationship with the study drug are denied in study 262-09-001 and whose symptoms are still emerged at the time of initiation of this study
Description

Serious Adverse Event | Relationship Investigational New Drugs Rejected | Symptoms Present

Type de données

boolean

Alias
UMLS CUI [1]
C1519255
UMLS CUI [2,1]
C0439849
UMLS CUI [2,2]
C0013230
UMLS CUI [2,3]
C1548437
UMLS CUI [3,1]
C1457887
UMLS CUI [3,2]
C0150312
patients who met the exclusion criteria of study 262-09-001 during the study period of study 262-09-001
Description

Exclusion Criteria Fulfill Clinical Trial Specified

Type de données

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1550543
UMLS CUI [1,3]
C0008976
UMLS CUI [1,4]
C0205369
female patients who wish to become pregnant during the study period of study 262-09-002 or within 4 weeks after the study
Description

Pregnancy intended

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C1283828
patients otherwise judged by the investigator or subinvestigator to be inappropriate for inclusion in the study
Description

Study Subject Participation Status Inappropriate

Type de données

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1548788
Retour au début de la page

Similar models

Eligibility Diabetes, Type 2 NCT01634282

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Clinical Trial Specified Completed
Item
patients who completed study 262-09-001 (namely, patients who visited the hospital at visit week 24）
boolean
C0008976 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
C0205197 (UMLS CUI [1,3])
Informed Consent
Item
patients who are capable of giving informed consent prior to participating in this clinical study
boolean
C0021430 (UMLS CUI [1])
Contraceptive methods | Partner Contraceptive methods
Item
patients who are able to take contraceptive measures to avoid pregnancy of the patient or the patient's partner for the entire study period and for 4 weeks after the study (end of the post-observation period)
boolean
C0700589 (UMLS CUI [1])
C0682323 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Patients Withdrawn Clinical Trial Specified
Item
patients who withdrew from study 262-09-001
boolean
C0030705 (UMLS CUI [1,1])
C2349954 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,4])
Serious Adverse Event | Relationship Investigational New Drugs
Item
patients who experienced serious adverse events that the relationship with the study drug was not denied in study 262-09-001
boolean
C1519255 (UMLS CUI [1])
C0439849 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
Serious Adverse Event | Relationship Investigational New Drugs Rejected | Symptoms Present
Item
patients who experienced serious adverse events that the relationship with the study drug are denied in study 262-09-001 and whose symptoms are still emerged at the time of initiation of this study
boolean
C1519255 (UMLS CUI [1])
C0439849 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C1548437 (UMLS CUI [2,3])
C1457887 (UMLS CUI [3,1])
C0150312 (UMLS CUI [3,2])
Exclusion Criteria Fulfill Clinical Trial Specified
Item
patients who met the exclusion criteria of study 262-09-001 during the study period of study 262-09-001
boolean
C0680251 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205369 (UMLS CUI [1,4])
Pregnancy intended
Item
female patients who wish to become pregnant during the study period of study 262-09-002 or within 4 weeks after the study
boolean
C0032961 (UMLS CUI [1,1])
C1283828 (UMLS CUI [1,2])
Study Subject Participation Status Inappropriate
Item
patients otherwise judged by the investigator or subinvestigator to be inappropriate for inclusion in the study
boolean
C2348568 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial